The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 17, 2015

Filed:

Oct. 19, 2011
Applicants:

Rama Shankar, Hyderabad, IN;

Vadali Lakshmana Rao, Hyderabad, IN;

Palla Vijay Kumar, Hyderabad, IN;

Saidugari Swamy, Hyderabad, IN;

Dasari Srinivasa Rao, Hyderabad, IN;

Srinivasa Rao Potla, Hyderabad, IN;

Mittapelly Nagaraju, Hyderabad, IN;

Jaldu Ravikanth, Hyderabad, IN;

Vijaya Krishna Ravi, Hyderabad, IN;

Seshadri Rao Manukonda, Hyderabad, IN;

Dandala Ramesh, Hyderabad, IN;

Inventors:

Rama Shankar, Hyderabad, IN;

Vadali Lakshmana Rao, Hyderabad, IN;

Palla Vijay Kumar, Hyderabad, IN;

Saidugari Swamy, Hyderabad, IN;

Dasari Srinivasa Rao, Hyderabad, IN;

Srinivasa Rao Potla, Hyderabad, IN;

Mittapelly Nagaraju, Hyderabad, IN;

Jaldu Ravikanth, Hyderabad, IN;

Vijaya Krishna Ravi, Hyderabad, IN;

Seshadri Rao Manukonda, Hyderabad, IN;

Dandala Ramesh, Hyderabad, IN;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07C 231/12 (2006.01); C07C 237/22 (2006.01); C07C 233/00 (2006.01); C07C 43/205 (2006.01); C07C 231/14 (2006.01); C07C 43/215 (2006.01); C07C 241/00 (2006.01); C07C 255/29 (2006.01); C07C 247/10 (2006.01); C07D 307/33 (2006.01);
U.S. Cl.
CPC ...
C07C 231/14 (2013.01); C07C 43/215 (2013.01); C07C 231/12 (2013.01); C07C 241/00 (2013.01); C07C 247/10 (2013.01); C07C 255/29 (2013.01); C07D 307/33 (2013.01);
Abstract

The present invention provides novel process for the preparation of renin inhibitor Aliskiren or its derivatives, and its pharmaceutically acceptable salts. The present invention also provides novel intermediates used in the preparation of Aliskiren.


Find Patent Forward Citations

Loading…